SCHEMBL4471889

SCHEMBL4471889

COc1cc(CNCCC(=O)Nc2cccc(NC(=O)CCN3CCC(OC(=O)N(c4ccccc4-c4ccccc4)N(C(=O)O)c4ccccc4-c4ccccc4)CC3)c2)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 13/20 0.49
ADRB2 P07550 12/20 0.49
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4474416 0.92 CHRM3 (0.46) CHRM3ADRB2
SCHEMBL4482049 0.90 CHRM3 (0.45) CHRM3ADRB2
SCHEMBL4475312 0.87 CHRM3 (0.45) CHRM3ADRB2CHRM2
SCHEMBL265828 0.86 CHRM3 (0.61) CHRM3ADRB2CHRM2
SCHEMBL4493377 0.86 CHRM3 (0.43) CHRM3ADRB2
SCHEMBL4494233 0.83 CHRM3 (0.41) CHRM3ADRB2
SCHEMBL4482057 0.82 CHRM3 (0.48) CHRM3ADRB2
SCHEMBL4474750 0.82 CHRM3 (0.41) CHRM3ADRB2
SCHEMBL4483286 0.82 CHRM3 (0.42) CHRM3ADRB2
SCHEMBL4475453 0.82 CHRM3 (0.43) CHRM3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632847-B2 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(3-[3-(4-hydroxybenzylamino)propionylamino]benzoylamino)ethyl)piperidin-4-yl ester THERAVANCE, INC. (US) 2009-12-15 US disclosed